Evidence map›Paper›PMID 41387539›Full record

ArticleNature communications2025

Collision-induced ribosome degradation driven by ribosome competition and translational perturbations.

Sihan Li, Okuto Shounai, Misaki Kato, Ken Ikeuchi, Toshifumi Inada

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sihan LiDivision of RNA and gene regulation, Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo, Japan. li-sihan@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-0224-5795
Okuto ShounaiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Misaki KatoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
Ken IkeuchiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.ORCID http://orcid.org/0000-0002-9578-7920
Toshifumi InadaDivision of RNA and gene regulation, Institute of Medical Science, The University of Tokyo, Minato-Ku, Tokyo, Japan. toshiinada@ims.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-2695-588X

Funding

Japan Agency for Medical Research and Development (AMED) JP223fa627001Japan Agency for Medical Research and Development (AMED) JP23gm1110010MEXT | Japan Society for the Promotion of Science (JSPS) 25H00007MEXT | Japan Society for the Promotion of Science (JSPS) JP22H00401MEXT | Japan Society for the Promotion of Science (JSPS) JP23K19341
6 · The paper itself

Abstract

Individual stalling of catalytically inactive ribosomes at the start codon triggers ubiquitination of ribosomal protein uS3 and subsequent 18S rRNA decay. While collisions between ribosomes during translation elongation represent a more widespread form of translation perturbation, their impact on ribosome stability remains unknown. Here, we clarify a bifurcation in ubiquitination-mediated ribosome turnover, identifying a collision-induced branch of uS3 ubiquitination and small subunit destabilization in yeast. This pathway eliminates not only non-functional ribosomes but also translationally active ones with a prokaryotic-like decoding center, driven by competition with wild-type ribosomes due to differing translation rates. We further show that endogenous ribosomal subunit stoichiometry shifts toward a small-subunit-shortage state via ubiquitination upon perturbed translation triggered by the anti-cancer drug cisplatin and the growth phase transition. These findings reveal a mechanism by which ribosome dynamics generally affects ribosome stability, implicating ribosome dysfunction, heterogeneity, and stress-related translational disturbances in small subunit degradation.

Indexed as

Protein BiosynthesisRibosomesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCisplatinRibosomal ProteinsRNA, Ribosomal, 18SRNA StabilityUbiquitinationCisplatinRibosomal ProteinsRNA, Ribosomal, 18SSaccharomyces cerevisiae Proteins

Identifiers

PMID41387539
PMCPMC12700985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.